1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
Correspondence
You have full text access to this OnlineOpen article
To the Editor
Article first published online: 30 DEC 2003
DOI: 10.1002/hep.510340328
Copyright © 2001 American Association for the Study of Liver Diseases
1527-3350/asset/cover.gif?v=1&s=3cd983af6575c8dbfd6b47a63ffa95415ace15f8 "Hepatology")
Additional Information
How to Cite
de Sio, I., Castellano, L., De Girolamo, V., di Santolo, S. S., Marone, A., Del Vecchio Blanco, C. and Marone, G. (2001), To the Editor. Hepatology, 34: 609a–610. doi: 10.1002/hep.510340328
Publication History
- Issue published online: 30 DEC 2003
- Article first published online: 30 DEC 2003
References
- 1, , , , , , , et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001; 33:1124–1129.MEDLINE
- 2, , , , , , , et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long term results of percutaneous ethanol injection. Radiology 1995; 197:101–108.MEDLINE
- 3, , , , , . Tumor sizes determines the efficacy of percutaneous ethanol injection for treatment of small hepatocellular carcinoma. Hepatology 1992; 16:353–357.MEDLINE
- 4, , , , , , , et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma. A multicenter survey of evaluation practices and complication rates. Scand J Gastroenterol 1997; 32:1168–1173.MEDLINE